
The APAC Recap: Dyslipidemia at CAPP Live 2024 with Viet Le, DMSc, PA-C
Key Takeaways
- The 2022 AHA/ACC consensus emphasizes reclassifying high-risk ASCVD patients and targeting LDL-C levels of ≤55 mg/dL using non-statin therapies.
- Pitavastatin is highlighted as an effective alternative for statin-intolerant patients, reducing LDL-C levels by 30–49% when combined with ezetimibe or bempedoic acid.
Past APAC President Viet Le shares insights from CAPP 2024 on managing high-risk ASCVD, new non-statin therapies, and options for statin-intolerant patients.
In this episode of
One major point he discussed is the 2022 American Heart Association (AHA)/American College of Cardiology (ACC) expert consensus pathway for non-statin therapies, emphasizing the importance of reclassifying high-risk patients with atherosclerotic cardiovascular disease (ASCVD). Le advised cardiology PAs and NPs to recognize those with very high-risk ASCVD profiles and to aim for an LDL-cholesterol target (LDL-C) of ≤55 mg/dL, beyond standard statin therapy, using options like ezetimibe, bempedoic acid, and PCSK9 inhibitors.
A highlight from Le’s presentation was his advice on managing statin intolerance, a common referral reason in preventive cardiology. He discussed the benefits of pitavastatin, a lesser-known statin with a high success rate in patients who experience myalgia on other statins. Le explained that pitavastatin’s unique formulation, originating from research by a Japanese pharmaceutical company, makes it an effective alternative for lipid lowering in statin-intolerant patients, reducing LDL-C levels by 30–49% when used at 2 or 4 mg, especially when combined with ezetimibe or bempedoic acid.
To conclude, Le reviewed the 2022 expert consensus on non-statin therapies and discussed the importance of risk-enhancing factors, particularly in women with conditions like preeclampsia or premature menopause, which are often overlooked yet critical in risk assessment. Their discussion emphasizes practical, evidence-based approaches to lipid management, equipping cardiology providers to optimize patient care.
All episodes of The APAC Recap will be available on HCPLive.com and on our















































































